An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule

by Hörig, Heidi, Papadopoulos, Nicholas J., Vegh, Zsuzsanna, Palmieri, Edith, Angeletti, Ruth H., Nathenson, Stanley G.
Published 1997

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell

by González, Pablo A., Carreño, Leandro J., Coombs, Daniel, Mora, Jorge E., Palmieri, Edith, Goldstein, Byron, Nathenson, Stanley G., Kalergis, Alexis M.
Published 2005

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy

by Lázár-Molnár, Eszter, Scandiuzzi, Lisa, Basu, Indranil, Quinn, Thomas, Sylvestre, Eliezer, Palmieri, Edith, Ramagopal, Udupi A., Nathenson, Stanley G., Guha, Chandan, Almo, Steven C.
Published in EBioMedicine (2017)

Predominant occupation of the class I MHC molecule H-2K(wm7) with a single self-peptide suggests a mechanism for its diabetes-protective effect

by Brims, Daniel R., Qian, Jie, Jarchum, Irene, Mikesh, Leann, Palmieri, Edith, Ramagopal, Udupi A., Malashkevich, Vladimir N., Chaparro, Rodolfo J., Lund, Torben, Hattori, Masakazu, Shabanowitz, Jeffrey, Hunt, Donald F., Nathenson, Stanley G., Almo, Steven C., DiLorenzo, Teresa P.
Published 2010